Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.

IF 8.2 1区医学 Q1 HEMATOLOGY Haematologica Pub Date : 2025-03-06 DOI:10.3324/haematol.2025.287325

Enrica Antonia Martino, Annalisa Pitino, Massimo Offidani, Roberta Della Pepa, Alessandro Gozzetti, Velia Bongarzoni, Antonio Maroccia, Valeria Amico, Paola Stefanoni, Elena Zamagni, Sofia Terlizzi, Daniele Derudas, Salvatore Palmieri, Rosario Bianco, Concetta Conticello, Marino Brunori, Angela Rago, Flavia Lotti, Raffaele Fontana, Nicola Sgherza, Elena Rossi, Anna Maria Cafro, Massimiliano Arangio Febbo, Angela Maria Quinto, Claudio Cerchione, Gloria Margiotta Casaluci, Annalisa Citro, Catello Califano, Renato Zambello, Silvia Mangiacavalli, Carmine Liberatore, Gabriele Buda, Claudio De Magistris, Angela Amendola, Ernesto Vigna, Antonella Bruzzese, Emiliano Barbieri, Micol Quaresima, Daniela Roccotelli, Francesca Farina, Jacopo Micozzi, Iolanda Donatella Vincelli, Giuseppe Tarantini, Elisabetta Antonioli, Sara Aquino, Alessandro Maggi, Alessandra Lombardo, Giuseppe Bertuglia, Anna Furlan, Anna Mele, Ombretta Annibali, Emilia Cotzia, Pietro Benvenuti, Lorenzo De Paoli, Gregorio Barilà, Sonia Morè, Valerio De Stefano, Francesco Di Raimondo, Maria Teresa Petrucci, Niccolò Bolli, Pellegrino Musto, Antonino Neri, Fortunato Morabito, Giovanni Tripepi, Massimo Gentile

{"title":"Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomidedexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.","authors":"Enrica Antonia Martino, Annalisa Pitino, Massimo Offidani, Roberta Della Pepa, Alessandro Gozzetti, Velia Bongarzoni, Antonio Maroccia, Valeria Amico, Paola Stefanoni, Elena Zamagni, Sofia Terlizzi, Daniele Derudas, Salvatore Palmieri, Rosario Bianco, Concetta Conticello, Marino Brunori, Angela Rago, Flavia Lotti, Raffaele Fontana, Nicola Sgherza, Elena Rossi, Anna Maria Cafro, Massimiliano Arangio Febbo, Angela Maria Quinto, Claudio Cerchione, Gloria Margiotta Casaluci, Annalisa Citro, Catello Califano, Renato Zambello, Silvia Mangiacavalli, Carmine Liberatore, Gabriele Buda, Claudio De Magistris, Angela Amendola, Ernesto Vigna, Antonella Bruzzese, Emiliano Barbieri, Micol Quaresima, Daniela Roccotelli, Francesca Farina, Jacopo Micozzi, Iolanda Donatella Vincelli, Giuseppe Tarantini, Elisabetta Antonioli, Sara Aquino, Alessandro Maggi, Alessandra Lombardo, Giuseppe Bertuglia, Anna Furlan, Anna Mele, Ombretta Annibali, Emilia Cotzia, Pietro Benvenuti, Lorenzo De Paoli, Gregorio Barilà, Sonia Morè, Valerio De Stefano, Francesco Di Raimondo, Maria Teresa Petrucci, Niccolò Bolli, Pellegrino Musto, Antonino Neri, Fortunato Morabito, Giovanni Tripepi, Massimo Gentile","doi":"10.3324/haematol.2025.287325","DOIUrl":null,"url":null,"abstract":"Not available.","PeriodicalId":12964,"journal":{"name":"Haematologica","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2025-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haematologica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3324/haematol.2025.287325","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Not available.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.